Last update 21 Nov 2024
Recombinant anti-BDCA2 humanized monoclonal antibody(Sunshine Guojian)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms 重组抗BDCA2人源化单克隆抗体（三生国健药业） |
Target |
Mechanism BDCA2 inhibitors(C-Type lectin domain family 4 member C inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Recombinant anti-BDCA2 humanized monoclonal antibody(Sunshine Guojian)一项随机、双盲、安慰剂对照、单次给药剂量递增的I期临床研究，旨在评价SSGJ-626单次皮下注射给药在中国健康成年受试者中的安全性、耐受性及药代动力学特征
[Translation] A randomized, double-blind, placebo-controlled, single-dose escalation Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of SSGJ-626 after a single subcutaneous injection in healthy Chinese adult subjects
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SSGJ-626 in Healthy Adult Subjects
100 Clinical Results associated with Recombinant anti-BDCA2 humanized monoclonal antibody(Sunshine Guojian)
Login to view more data
100 Translational Medicine associated with Recombinant anti-BDCA2 humanized monoclonal antibody(Sunshine Guojian)
Login to view more data
100 Patents (Medical) associated with Recombinant anti-BDCA2 humanized monoclonal antibody(Sunshine Guojian)
Login to view more data
100 Deals associated with Recombinant anti-BDCA2 humanized monoclonal antibody(Sunshine Guojian)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lupus Erythematosus, Cutaneous | Phase 1 | CN | 14 Nov 2024 | |
| Systemic Lupus Erythematosus | Phase 1 | CN | 14 Nov 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free